ÂÜÀòÂÒÂ×

Antonio E. Civitarese is a seasoned biotech development executive with extensive experience in clinical and pre-clinical development, particularly in the fields of metabolic diseases, obesity, and rare diseases. They have held leadership positions at prominent institutions including the Pennington Biomedical Research Center and Novo Nordisk, and are currently the Head of Clinical Pipeline and Programs Development at Structure Therapeutics. Throughout their career, Antonio has demonstrated a strong ability to drive corporate growth and innovation by translating strategic goals into actionable plans. They co-founded BioShore Partners and the Awaken Health MD obesity clinic, showcasing their commitment to addressing unmet clinical needs in metabolic health. Antonio holds a PhD in Biotechnology from Deakin University and possesses multilingual skills in English, Italian, and Portuguese.